Examiner: VALENROD, YEVGENY

Tech Center 1600 • Art Units: 1621 1628 1672

This examiner grants 73% of resolved cases

Performance Statistics

72.6%

Allow Rate

+12.6% vs TC avg

1,051

Total Applications

+25.1%

Interview Lift

931

Avg Prosecution Days

Based on 1018 resolved cases, 2023–2026

2.3%

§101 Eligibility

18.3%

§102 Novelty

38.1%

§103 Obviousness

20.9%

§112 Clarity

App #	Title	Status	Assignee
19373642	COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS	Final Rejection	Antecip Bioventures II LLC
18531590	BUPROPION AS A MODULATOR OF DRUG ACTIVITY	Non-Final OA	ANTECIP BIOVENTURES II LLC

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.